However, Han et al. reported that cardiac hypertrophy, when induced by high levels of FGF-23, could be attenuated by the administration of soluble klotho protein in a mouse model [46], whereas Pastor-Arroyo reported the absence of ventricular hypertrophy in a mouse model without kidney disease [45]. This evidence concerns the gene FGF23 and Ventricular hypertrophy.